Redcare's Rapid Growth Soars in Q1 with 2.1% Profit Margin; Achieves e-Rx Breakthrough in Germany

• Group sales in Q1 were EUR 560M, up 51% from the prior year
• Non-Rx sales grew by 20% to EUR 404M, while Rx sales in Germany increased by 7%
• Adjusted EBITDA margin was at 2.1%, with a total of EUR 11.7M, up 33% year over year
• Active customer base increased to 11.2M, up 1.5M year over year
• E-Rx became the new standard in Germany, with over 70% already electronic
• Approval received for eHealth-CardLink, to be launched in Shop Apotheke app by early May

The next important date, Quarterly report, at Redcare Pharmacy is on 25.04.2024.

At this time, the index MDAX was at 26.368,02PKT (-1,15 %).

Redcare Pharmacy

+2,55 %

-1,68 %

-13,40 %

-4,78 %

+44,43 %

-25,28 %

+262,76 %

+314,84 %

+314,84 %

ISIN:NL0012044747WKN:A2AR94

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max